I am a Postdoctoral Fellow at the Nova School of Business and Economics, working on the "HI-PRIX - Health Innovation Next Generation Payment & Pricing Models" (WP4), under the supervision of Professor Pedro Pita Barros.
My main field of study is at the intersection between Health Economics and Industrial Organization. My scientific interests include pharmaceutical regulation, external reference pricing, and innovation.
I obtained my PhD in Economics at the University of Verona in 2024 with a Thesis titled "Cross-Country Interactions in Pharmaceutical Regulations", supervised by Professor Paolo Pertile.
New (fancier) website at this link
April 2026: "The Impact of Health Technology Assessment on Pharmaceutical Prices: Evidence from Germany" accepted for publication at the European Journal of Health Economics.
17 May 2026: Invited guest lecture on "Pricing Without Borders: Spillovers of External Reference Pricing in Pharmaceutical Regulation" for the course in Health Economics and Policy (BSc), University of Insubria.
1-2 June 2026: I will present "The Clinical Trial Balloon: How Strategic Eligibility Design Inflates Therapeutic Benefit of Cancer Drugs" at the X American-European Health Economics Study Group at the Hertie School, Berlin.
15-17 July 2026: I will present "The Clinical Trial Balloon: How Strategic Eligibility Design Inflates Therapeutic Benefit of Cancer Drugs" and "On the Long-Term Effects of Most Favored Nation Drug Pricing" at the EuHEA Conference 2026 in Rotterdam.